Exagen (XGN) Depreciation & Amortization (CF) (2018 - 2026)
Exagen's (XGN) quarterly Depreciation & Amortization (CF) came in at $599000.0 in Q1 2026, up 36.14% YoY from $440000.0 in Q1 2025, and little changed on a QoQ basis from $600000.0 in Q4 2025.
Exagen (XGN) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Exagen (XGN) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $599000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 36.14% year-over-year to $599000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 33.47% YoY) and the FY2025 annual result came in at $2.1 million, up 22.85% from the prior year.
- Depreciation & Amortization (CF) was little changed at $599000.0 in Q1 2026, from $600000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $612000.0 in Q3 2025 to a low of $283000.0 in Q1 2022.
- A 5-year average of $480352.9 and a median of $466000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 95.41% — and 2024, when it slumped 30.25%.
- Tracing XGN's Depreciation & Amortization (CF) over 5 years: stood at $520000.0 in 2022, then retreated by 2.5% to $507000.0 in 2023, then dropped by 18.15% to $415000.0 in 2024, then jumped by 44.58% to $600000.0 in 2025, then dropped by 0.17% to $599000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $599000.0 (Q1 2026), $600000.0 (Q4 2025), and $612000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 331.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 196.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 41.05 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 67.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 292.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.52 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 51.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 13.30 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 146.00 Mn |
| 10 | Exagen | 158.28 Mn | 133.68 Mn | 12.22 Mn | 628,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 628,000.00 |
| Jun 30, 2026 | 628,000.00 |
| Mar 31, 2026 | 599,000.00 |
| Mar 31, 2026 | 599,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 612,000.00 |
| Sep 30, 2025 | 612,000.00 |
| Jun 30, 2025 | 466,000.00 |
| Jun 30, 2025 | 466,000.00 |
| Mar 31, 2025 | 440,000.00 |
| Mar 31, 2025 | 440,000.00 |
| Dec 31, 2024 | 415,000.00 |
| Dec 31, 2024 | 415,000.00 |
| Sep 30, 2024 | 422,000.00 |
| Sep 30, 2024 | 422,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 458,000.00 |
| Mar 31, 2024 | 458,000.00 |